Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
                
Learn More
Learn More
                                    PA28 Activator alpha Subunit/PSME1 Antibody (016), Biotin, Novus Biologicals™
                                    
                                    
                                    
                                    
                                
                            
                            
                            
                            
Rabbit Monoclonal Antibody
Supplier: Novus Biologicals NBP290298B
Description
PA28 Activator alpha Subunit/PSME1 Monoclonal specifically detects PA28 Activator alpha Subunit/PSME1 in Human samples. It is validated for Western Blot, ELISA.Specifications
| PA28 Activator alpha Subunit/PSME1 | |
| Monoclonal | |
| Biotin | |
| PBS | |
| Rabbit | |
| Protein A purified | |
| RUO | |
| 5720 | |
| Store at 4°C in the dark. | |
| IgG | 
| Western Blot, ELISA | |
| 16 | |
| Western Blot, ELISA | |
| 11S regulator complex alpha subunit, 11S regulator complex subunit alpha, 29-kD MCP activator subunit, IFI5111MGC8628, IGUP I-5111, Interferon gamma up-regulated I-5111 protein, interferon-gamma IEF SSP 5111, interferon-gamma-inducible protein 5111, PA28a, PA28alphaActivator of multicatalytic protease subunit 1, proteasome (prosome, macropain) activator subunit 1 (PA28 alpha), Proteasome activator 28 subunit alpha, proteasome activator complex subunit 1, proteasome activator subunit-1, REGalpha, REG-alpha | |
| This antibody was obtained from a rabbit immunized with purified, recombinant Human PA28 Activator alpha Subunit/PSME1 (Q06323; Met1-Tyr249). | |
| 0.1 mL | |
| Primary | |
| Human | |
| Purified | 
                    Product Content Correction
                
                Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
			
            Spot an opportunity for improvement?Share a Content Correction